Trial site
Royal Stoke University Hospital
- 33running trials
- 13closed trials
The trials here
What the 46 trials at this site are about, from their registry records.
- Conditions
- Stroke9 trials
- Multiple myeloma8 trials
- Childhood cancers3 trials
- Coronary artery disease3 trials
- Cystic fibrosis3 trials
- Psoriatic arthritis3 trials
- Bronchiectasis2 trials
- Chronic kidney disease2 trials
- Deep vein thrombosis and pulmonary embolism2 trials
- Liver and biliary tract cancer2 trials
- Lung cancer2 trials
- Peripheral artery disease2 trials
- and 20 more
- Phase
- Phase 327 trials
- Phase 23 trials
- Phase 2/33 trials
- Phase 1/22 trials
- Status
- Recruiting20 trials
- Completed13 trials
- Active, not recruiting10 trials
- Not yet recruiting3 trials
- Lead sponsor
- Janssen Research & Development, LLC5 trials
- Hoffmann-La Roche3 trials
- Boehringer Ingelheim2 trials
- Eli Lilly and Company2 trials
- Joseph Broderick, MD2 trials
- and 29 more
Running trials
Not yet recruiting
Recruiting
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Recruiting
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Recruiting
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Recruiting
Identifying the Causes and Risk Factors of Pulmonary Exacerbations in Cystic Fibrosis
Recruiting
Recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Recruiting
Recruiting
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Closed-loop for People Living With Cystic Fibrosis Related Diabetes
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Recruiting
The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)
Recruiting
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Recruiting
Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)
Active, not recruiting
Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple myeloma5 recruiting
- Stroke4 recruiting
- Bronchiectasis2 recruiting
- Coronary artery disease2 recruiting
- Peripheral artery disease2 recruiting
- Acute myeloid leukaemia1 recruiting
- ALS (motor neurone disease)1 recruiting
- Aortic stenosis1 recruiting
- Childhood cancers1 recruiting
- Chronic kidney disease1 recruiting
- Colorectal cancer1 recruiting
- Crohn's disease1 recruiting
- Cystic fibrosis1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- IgA nephropathy1 recruiting
- Liver and biliary tract cancer1 recruiting
- Myelodysplastic syndromes1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Polycystic kidney disease1 recruiting
- Psoriasis1 recruiting
- Psoriatic arthritis1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis (CF)
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial
Completed
HEMOglobin Transfusion Threshold in Traumatic Brain Injury OptimizatioN: The HEMOTION Trial
Completed
Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026